Malaria

Policy guidance

New guidance on mass drug administration for falciparum malaria

Recent progress in malaria control, including the drive towards elimination of malaria in some settings and the availability of new antimalarial medicines, has renewed interest in the role that mass drug administration (MDA) can play in some settings. This manual is intended to provide operational guidance on MDA and should be adapted to local circumstances.

Updated recommendations on universal coverage with long-lasting insecticidal nets

Long-lasting insecticidal nets (LLINs) have played an important role in reducing the global malaria burden since 2000. They are a core prevention tool used widely by people at risk of malaria, and part of pillar 1 of the Global Technical Strategy for Malaria 2016–2030 is to ensure universal coverage for all people at risk of malaria using effective vector control.

Updated guidance for investigating suspected false-negative RDT results

Most of the currently available commercial rapid diagnostic test (RDT) kits work by detecting a specific protein expressed only by P. falciparum, called HRP2, in the blood of people infected with falciparum malaria. This updated information note provides countries with specific guidance on the implications of pfhrp2/pfhrp3 gene deletions in P. falciparum parasites and advises on procedures for investigating suspected false-negative RDT results.

New recommendations on pre-referral treatment of severe malaria

Severe malaria is a medical emergency. This information note describes how to use rectal artesunate for pre-referral treatment of severe malaria in children under 6 years of age in remote areas where comprehensive treatment is not available, so that cases of suspected malaria can be treated without delay pending immediate transfer to a higher-level facility.

New guidance on malaria elimination

The malaria landscape has changed significantly since WHO launched the first field manual for malaria elimination in 2007. This new framework (released March 2017) provides guidance on the tools, activities and strategies required to achieve malaria elimination and prevent re-establishment of transmission in countries, regardless of where they lie across the spectrum of transmission intensity.

Diagnostic icon

Malaria diagnostic testing improves the quality of care for all patients with febrile illnesses. It is essential for both rapid and effective disease management and malaria surveillance. This section includes policy recommendations, operational manuals and other materials focused on the development, evaluation and use of malaria diagnostic tests.

2017

2016

2014

2013

2011

Funding proposal development

This document is intended to facilitate the proposal development process for all malaria-related policies and interventions currently recommended by WHO.

Efficacious antimalarial medicines are critical to malaria control. Continuous monitoring of their efficacy is needed to inform treatment policies and to ensure the early detection of and response to drug resistance. This section includes technical manuals on antimalarial efficacy monitoring, resistance and the global response.

2011

2009

2008

Funding proposal development

This document is intended to facilitate the proposal development process for all malaria-related policies and interventions currently recommended by WHO.

Elimination icon

Malaria elimination is the interruption of local transmission of a specified malaria parasite species in a defined geographic area. This section includes technical reviews, scenario planning tools, a global framework, and other materials to inform country planning and progress towards eliminating the disease.

2017

2015

2014

2012

Funding proposal development

This document is intended to facilitate the proposal development process for all malaria-related policies and interventions currently recommended by WHO.

Treatment icon

Malaria is a preventable and entirely treatable disease. Effective treatment reduces transmission of infection by reducing the infectious reservoir and by preventing the emergence and spread of resistance to antimalarial medicines. This section includes guidance on the procurement of antimalarial medicines, pharmaceutical product evaluations, treatment guidelines, field guides and other materials.

2017

2016

2015

2014

2013

2012

2011

2010

2009

Funding proposal development

This document is intended to facilitate the proposal development process for all malaria-related policies and interventions currently recommended by WHO.

Strong malaria surveillance systems are fundamental to making evidence-informed policy decisions and implementing the most effective mix of malaria interventions. WHO urges malaria-endemic countries to strengthen their disease surveillance, health information and vital registration systems. This section includes operational manuals.

2012

Funding proposal development

This document is intended to facilitate the proposal development process for all malaria-related policies and interventions currently recommended by WHO.

Vector control icon

Vector control is the main approach to prevent malaria and reduce transmission. Two forms of vector control are effective in a wide range of circumstances: insecticide-treated mosquito nets (ITNs) and indoor residual spraying of insecticides (IRS). In specific settings and under special circumstances, these core interventions can be supplemented by other methods. This section includes operational manuals, information notes and other resources.

2017

2016

2015

2014

2013

2012

2011

Funding proposal development

This document is intended to facilitate the proposal development process for all malaria-related policies and interventions currently recommended by WHO.